The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd.
The hedge fund reported an additional purchase of $3.8 million in Impinj Inc $PI, increasing its ownership stake to 10.68%.
Expert technical analysis of financial markets by JC Parets
by David
The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd.
The hedge fund reported an additional purchase of $3.8 million in Impinj Inc $PI, increasing its ownership stake to 10.68%.
by David
The largest insider transaction on today’s list comes in a Form 4 filed by Boxer Capital LLC.
The investment fund reported a purchase of roughly $35 million in Mirati Therapeutics $MRTX.
by David
The largest insider transaction on today’s list comes in a Form 4 filed by Michael Andrew Chambers, director of Sarepta Therapeutics $SRPT.
Chambers reported an additional purchase of 23,686 SRPT shares, equivalent to $2.5 million.
by David
The largest insider transaction on today’s list comes in a Form 4 filed by Michael Andrew Chambers, director of Sarepta Therapeutics $SRPT.
Chambers reported a purchase of SRPT shares worth $3.7 million.
by David
The largest insider transaction on today’s list comes in a Form 4 filed by Steven J. McLaughlin, founder and CEO of FT Partners, a fintech-focused investment banking firm.
McLaughlin revealed an additional purchase of $2.7 million in Expensify Inc $EXFY.
by David
The largest insider transaction on today’s list comes in a Form 4 filed by HF Direct Investments Pool, LLC.
The investment unit of the direct response marketing firm reported a purchase of $50 million in Westrock Coffee Company $WEST, increasing its ownership stake to 17.15%.
by David
The largest insider transaction on today’s list comes in a Form 4 filing from Steven J. McLaughlin of fintech-focused investment banking firm FT Partners.
McLaughlin revealed a purchase of $2.9 million in Expensify Inc $EXFY.
by David
The largest insider transaction on today’s list comes in a Form 4 filing from the CEO and chief business and strategic operations officer of Cerevel Therapeutics Holdings $CERE.
The two executives reported purchases for a combined amount of $2.5 million.